Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Copernicus Therapeutics" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Copernicus Therapeutics for you to read. Along with our medical data and news we also list Copernicus Therapeutics Clinical Trials, which are updated daily. BioPortfolio also has a large database of Copernicus Therapeutics Companies for you to search.
WIRB-Copernicus Group has completed the acquisition of KMR Group and Metrics Champion Consortium (MCC) for an undisclosed sum. The acquired...Read More... The post M&As this week: WIRB-Copernicus, AbCellera Biologics, Apricus Biosciences appeared first on Drug Development Technology.
Imagine, for a moment, that every drug on the market suddenly didn’t work because of the lack of an adequate delivery system. That’s precisely the situation gene therapy companies find themselves in today...
(Deutsche Forschungsgemeinschaft) Cardiologists from Berlin and Wrocaw to receive the award from the DFG and the Foundation for Polish Science / Award ceremony to take place on October 25 in Berlin.
The EU-funded AURORA project will develop technologies to turn data from the Sentinel-4 and Sentinel-5 missions – due to be launched as part of the European Space Agency’s Copernicus programme – into practical, actionable information that will help protect the health of European citizens.
Nabriva Therapeutics has completed the acquisition of Zavante Therapeutics for $97.5m. The acquisition will add the target company’s CONTEPO™ drug, which...Read More... The post M&As this week: Nabriva Therapeutics, Sangamo Therapeutics, Ryboquin appeared first on Drug Development Technology.
Based in San Diego of California, Jecure Therapeutics is engaged in the discovery of therapeutics to treat non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure Therapeutics president and CEO The post Roche’s Genentech agrees to buy Jecure Therapeutics appeared first on Pharmaceutical Business review.
The acquisition strengthens HiFiBiO Therapeutics’ strategic focus on identifying first-in-class targets for multiple immune cell types, as well as applying industry-leading technologies to develop diverse antibody therapeutics. Specific The post HiFiBiO Therapeutics buys early-stage biotech firm H-Immune Therapeutics appeared first on Pharma Business review.
Aquinox Pharmaceuticals, Summit Therapeutics and Global Blood Therapeutics are also making news
Pliant Therapeutics has raised $62m through a series B financing round from Cowen Healthcare Investments. The funding round also included participation...Read More... The post Deals and M&As this week: Pliant Therapeutics, MolMed, Modus Therapeutics appeared first on Drug Development Technology.
Vancouver, British Columbia--(Newsfile Corp. - June 27, 2018) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company"), and its subsidiary iCo Therapeutics Australia Pty Ltd., to...
Vancouver, British Columbia--(Newsfile Corp. - July 16, 2018) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company"), and its subsidiary iCo Therapeutics Australia Pty Ltd., to...
Impact Therapeutics has raised $30m through a series C financing round from Decheng Capital (Decheng). Existing investor Lilly Asian Ventures (LAV)...Read More... The post Deals this week: Impact Therapeutics, Sienna Biopharmaceuticals, Advanced Proteome Therapeutics appeared first on Drug Development Technology.
Edison Investment Research - Technology - SCISYS Group: After obtaining shareholder approval and subsequent court sanctioning, SCISYS has re-domiciled in the Republic of Ireland. The change will ensure that its German-based space business can continue to work on EU-funded space programmes, such as EGNOS, Galileo and Copernicus. SCISYS decided to finalise the move in Q4 as it is too risky to wait f...
Hoth Therapeutics Inc. (technology that creates a topical agent from existing therapeutics to treat skin diseases) filed for ...
Shares of Nabriva Therapeutics are rising this morning after the company announced it acquired privately-held Zavante Therapeutics.
HiFiBio Therapeutics acquired French biotech H-Immune Therapeutics, a privately held firm developing immuno-oncology therapie...
UK-based AdoRx Therapeutics, which is focused on discovering new cancer therapeutics, has secured an initial $10m investment round financed by Epidarex Capital and CRT Pioneer Fund (CPF).
20 - 21 February 2019, London, UK. Undoubtedly, the field of RNA therapeutics is currently undergoing a major expansion, and the potential for using RNA drugs for personalised medicines and immunotherapy, as well as to address genetic, infectious and chronic diseases will ensure the continued development of RNA therapeutics for years to come.
David Solomon’s entrance as Silence Therapeutics’ new CEO leads this week’s new hires. While Ireland-based Malin shakes up its board...
Carisma Therapeutics Inc., formerly CARMA Therapeutics, a privately─held biotechnology company focused on the development of macrophage─based immunotherapeutics, announced the close of a $53 million Series A
Under the agreement, the two companies will use e-therapeutics’ network-driven drug discovery platform for the identification of new therapeutics approaches to treat Type 2 diabetes, which currently accounts The post e-therapeutics, Novo Nordisk enter into research collaboration deal appeared first on Pharmaceutical Business review.
Summit Therapeutics plc('Summit', or the 'Company')Summit Therapeutics to Present at the Canaccord Genuity Growth ConferenceOxford, UK, and Cambridge, MA, US, 6 August 2018 - Summit Therapeutics p...
Ionis Pharmaceuticals affiliate Akcea Therapeutics has signed an agreement with biopharmaceutical company PTC Therapeutics for the commercialisation of its rare...Read More... The post PTC Therapeutics to commercialise Akcea’s two rare disease drugs appeared first on Pharmaceutical Technology.
On September 5, speakers at the Microbiome Therapeutics US conference shed light on the future of microbiome therapeutics, which is...Read More... The post From Parkinson’s to asthma: opportunities for microbiome-based therapeutics appeared first on Pharmaceutical Technology.